Audit summary
- Contracting party
- WellVi LLC d/b/a Coivas, New York, NY Documented
- Clinical provider
- Beluga Health (named on homepage) Documented
- Listed prices
- Compounded semaglutide from $119/mo; compounded tirzepatide from $199/mo Documented
- Billing interval
- Not stated on any page we read Unknown
- Pharmacy named
- No; "may vary" Unknown
- Guarantee
- Six-month minimum; refund only if weight is unchanged or higher Documented
What Coivas is
Coivas describes itself as a telehealth platform that connects patients with independent licensed providers. When we read the site in October 2026, its only live treatment line was weight loss, using compounded GLP-1 vials. An oral GLP-1 product was marked as launching soon, and other categories were listed as coming soon.
The terms of service name the contracting party as WellVi LLC doing business as Coivas, based in New York, NY. A later section of the same document refers to Coivas Health, Inc., and the site footer uses "Coivas Health." We found no street address for the company itself. The only street address on the homepage belongs to the clinical provider, Beluga Health, in Houston, Texas.
Two entity names in one contract aren't necessarily a problem. Still, if you ever dispute a charge, you'll want to know which company billed you. Your card statement and receipt should tell you.
02 / The moneyPublished pricing
The homepage listed two starting prices in October 2026. It also says there are no membership fees and that one price covers the prescription, medication and ongoing support. The shipping policy, updated May 7, 2026, says expedited shipping is included at no extra charge.
Compounded semaglutide
From $119/mo
Vial. Listed October 2026. Dose tiers not shown publicly.
Compounded tirzepatide
From $199/mo
Vial. Listed October 2026. Dose tiers not shown publicly.
Membership fee
None stated
Per the homepage. The refund policy still mentions a membership fee case (see below).
Due upfront vs. recurring
"From" means the lowest tier. The step that shows your actual price sits inside the intake flow, and our reader couldn't open it. So we can't tell you what is due at checkout for a given dose. The terms say subscription services are charged on a recurring basis at the then-current rate, and that insurance isn't accepted.
The billing cycle isn't published. None of the pages we read says whether you're billed every 28 days, every four weeks or once a calendar month. That matters. A 28-day cycle means 13 charges a year, not 12. Our guide to comparing GLP-1 fees without double counting walks through the math.
The homepage FAQ says your monthly price stays fixed while you remain on the same medication and treatment plan. The terms say prices may change with 30 days' notice. Those two statements can both hold only if a "plan" is defined narrowly. Ask whether a dose increase counts as a new plan.
Medication and pharmacy
Coivas lists compounded semaglutide and compounded tirzepatide, both as vials. We saw no FDA-approved branded GLP-1 on its treatment list. To its credit, the homepage states plainly that the FDA does not review or approve compounded medications for safety or effectiveness.
No pharmacy is named. The homepage says medication comes from state-licensed 503A compounding pharmacies and 503B outsourcing facilities. It adds that the dispensing pharmacy may vary by location, medication, availability and provider preference. The terms say Coivas is not a pharmacy and that dispensing pharmacies are NABP-accredited. One FAQ answer mentions only 503A pharmacies, while another names both types. Because the pharmacy can change, you can't check it before you pay. Our explainer on reviewing a provider whose pharmacy isn't named covers what to ask instead.
Since Coivas ships vials, one FDA point is worth knowing. The agency says it has received adverse-event reports tied to dosing errors with compounded injectable semaglutide. It also advises discarding multi-dose vials 28 days after first use. Ask your prescriber exactly how your vial should be measured and stored.
The efficacy marketing
The homepage headline promises "Guaranteed fat loss." A second line advertises losing 20% of body weight, with an asterisk noting that results vary and aren't guaranteed. The supporting citation is SURMOUNT-1, a published tirzepatide trial. A trial of tirzepatide tells you about that trial's product. It doesn't tell you how a particular compounded product will perform. The homepage also notes that its images may feature models and that some content may be AI-generated.
04 / The careClinical model
The model is asynchronous. You complete a short online quiz with no in-person visit, and a licensed provider reviews your intake. The homepage claims most users are prescribed within one day. We can't verify that claim. After you start, you can message your assigned clinician through the member dashboard. Patients already on a GLP-1 can transfer by providing proof of a current prescription, and the provider decides whether to continue at that dose.
Separate telehealth-consent and treatment-consent pages are linked from the footer. We didn't review those for this article.
Privacy note
The privacy policy (updated September 30, 2026) says Coivas does not sell information that directly identifies you. It also lists advertising and analytics partners, including Facebook, Google Ads and Criteo. It says sharing certain online identifiers with ad partners may count as a "sale" under California law, and that the site doesn't respond to browser Do Not Track signals.
05 / The exitCancellation, refunds and the guarantee
Cancellation
You can cancel at any time through the patient portal or by contacting support. The homepage FAQ ties the cutoff to your shipment. Cancel before the upcoming shipment is processed to avoid the next charge. If it has already been processed, the cancellation applies to the following cycle. The refund policy (updated May 7, 2026) says cancellation takes effect at the end of the current billing period. Since the cycle length isn't published, find your processing date in your account early.
Refunds
Per the refund policy, dispensed medication can't be returned. You have 7 days from delivery to report a wrong, damaged or apparently compromised shipment. For a confirmed medication error or defect, you choose a replacement or a full refund. Refunds are listed for a consultation that never happened and for duplicate charges. If no prescription is issued after a membership fee was paid, refunds are reviewed case by case. That clause sits oddly beside the homepage's "no membership fees" claim. Approved refunds take 5 to 10 business days to reach your card.
The money-back guarantee, as written
The headline says to try Coivas risk-free. The terms (updated July 6, 2026) set these conditions:
- At least six consecutive months of continuous paid enrollment.
- You must be a new customer, with your starting weight verified within 7 days of enrolling.
- No gaps, pauses, failed payments, chargebacks or disputes during that period.
- No other weight-loss medication in the 12 months before enrolling, and no microdosing protocol.
- Compounded semaglutide or tirzepatide only. Branded GLP-1s are excluded.
- A claim emailed within 40 days of your final shipment, verified by a provider attestation (at your cost) or a short video.
The key condition is the weight test. The terms require that your "verified final weight is equal to or greater than your verified starting weight." Read literally, losing any weight at all, even a pound, makes you ineligible. The refund covers subscription fees actually paid, and the terms say the guarantee doesn't promise weight loss or a prescription.
"Guaranteed fat loss" and the guarantee in the terms describe different things. The terms only cover people who lost nothing over six paid months. Don't choose Coivas because of the guarantee. Choose it, if you do, on price and care model. Our guide to reviewing a cancellation policy fairly explains how we weigh terms like these.
State availability
The homepage says Coivas is available in all 50 states. We didn't find a state-by-state list or any state-specific exclusions. Treat this as a claim until the intake flow confirms your state.
07 / The regulatorFDA warning letters
We found no FDA warning letter in our search as of October 2026. Here is what we searched. We ran the FDA's warning-letter database search, but its results table didn't render for our reader. We read the FDA's March 3, 2026 announcement of 30 warning letters to telehealth companies over compounded GLP-1 marketing, which doesn't name the recipients. We checked a third-party compounded GLP-1 enforcement tracker. And we ran web searches for "Coivas," "Coivas Health" and "WellVi" with "warning letter." Finding nothing doesn't mean a company is cleared.
08 / The recordEvidence ledger
Documented stated on Coivas's own pages, read October 2026. Claimed marketing statement we couldn't check independently. Unknown not published, or not readable to us.
| Claim | What the page says | Evidence level |
|---|---|---|
| Low starting price | Semaglutide from $119/mo; tirzepatide from $199/mo (homepage) | Documented |
| No membership fees | Homepage says one price, no membership fee; refund policy references a membership-fee case | Claimed |
| Price never changes | FAQ: fixed on same medication and plan. Terms: prices may change with 30 days' notice | Claimed |
| Billing cycle | Recurring at then-current rate; interval not stated | Unknown |
| Shipping included | Expedited shipping at no extra charge (shipping policy) | Documented |
| Pharmacy | 503A/503B facilities, NABP-accredited; not named; may vary | Unknown |
| Prescribed within a day | "Most users," per homepage | Claimed |
| Money-back guarantee | Six months paid; final weight must equal or exceed starting weight; other conditions | Documented |
| All 50 states | Homepage statement; no state list found | Claimed |
| Disputes | Binding arbitration in New York under AAA rules; New York law | Documented |
What we could not verify
- Dose-tier prices and the total due at checkout. The intake flow was closed to our reader.
- The billing interval, and whether a dose change counts as a new "plan" for the price promise.
- Which pharmacy will fill a given order.
- LegitScript status. The lookup link on the homepage returned no listing to our reader.
- The claim that most users are prescribed within one day, and the all-50-states claim.
Who it may fit
Coivas may suit an adult who wants an asynchronous, message-based compounded GLP-1 program with no published membership fee, and who is comfortable confirming dose pricing and the billing date during intake. It's a weaker fit if you want branded medication, if you want to know the pharmacy before paying, or if the guarantee is your main reason for trying it.
11 / The checklistQuestions to ask before paying
- What will I pay at my starting dose, and what will I pay after my first dose increase?
- How long is the billing cycle: 28 days, four weeks or a calendar month?
- Does a dose change count as a new plan under the price-lock promise?
- Which pharmacy will fill my first order, and where is it licensed?
- What is my shipment processing date, so I know my cancellation cutoff?
- Which company will appear on my card statement: WellVi LLC or Coivas Health, Inc.?
Reading the terms yourself?
If you start an intake, read the guarantee section, then confirm your dose price and billing date before you pay.
We may earn a commission if you sign up. Prices listed October 2026; confirm at checkout.
FAQ
How much does Coivas cost?
In October 2026 the Coivas homepage listed compounded semaglutide from $119 a month and compounded tirzepatide from $199 a month. Those are starting prices. Dose-based pricing sits inside the intake flow, so confirm the exact amount and billing date at checkout.
Does Coivas really offer a money-back guarantee?
Its terms describe one, but eligibility is narrow. As written in the terms dated July 6, 2026, it requires at least six consecutive months of paid enrollment and a verified final weight equal to or greater than your verified starting weight, plus several other conditions.
Which pharmacy fills Coivas prescriptions?
Coivas does not name one. Its pages say medication comes from state-licensed 503A compounding pharmacies or 503B outsourcing facilities, and that the dispensing pharmacy can vary by location, medication and availability.
How do I cancel Coivas?
Through the patient portal or by contacting support. The homepage FAQ says to cancel before your upcoming shipment is processed if you want to avoid the next charge.
Is Coivas medication FDA-approved?
No. Coivas lists compounded semaglutide and compounded tirzepatide, and its own homepage says the FDA does not review or approve compounded medications for safety or effectiveness.
Sources
- Coivas, homepage, treatments and FAQ. coivas.com (read October 2026).
- Coivas, Terms of Service, updated July 6, 2026. coivas.com/terms (read October 2026).
- Coivas, Return Policy, updated May 7, 2026. coivas.com/return-policy (read October 2026).
- Coivas, Shipping Policy, updated May 7, 2026. coivas.com/shipping-policy (read October 2026).
- Coivas, Privacy Policy, updated September 30, 2026. coivas.com/privacy (read October 2026).
- U.S. FDA, "FDA's concerns with unapproved GLP-1 drugs used for weight loss," updated October 1, 2026. fda.gov
- U.S. FDA, press announcement on warning letters to 30 telehealth companies, March 3, 2026. fda.gov
- U.S. FDA, Warning Letters database. fda.gov (searched October 2026).
- The Rx Index, compounded GLP-1 enforcement tracker (third party). therxindex.com (read October 2026).